TY  - JOUR
T1  - Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator
AU  - Watanabe, Hiroshi
DO  - 10.15420/ecr.2017:22:2
UR  - https://doi.org/10.15420/ecr.2017:22:2
JO  - European Cardiology Review 2018;13(1):35–7.
Y1  - 2018
PB  - Radcliffe Cardiology
ER  -